0001140361-17-008384.txt : 20170221 0001140361-17-008384.hdr.sgml : 20170220 20170221170749 ACCESSION NUMBER: 0001140361-17-008384 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170127 FILED AS OF DATE: 20170221 DATE AS OF CHANGE: 20170221 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: uniQure N.V. CENTRAL INDEX KEY: 0001590560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: MEIBERGDREFF 61 CITY: AMSTERDAM STATE: P7 ZIP: 1005 BA BUSINESS PHONE: 31-20-5667394 MAIL ADDRESS: STREET 1: MEIBERGDREFF 61 CITY: AMSTERDAM STATE: P7 ZIP: 1005 BA FORMER COMPANY: FORMER CONFORMED NAME: uniQure B.V. DATE OF NAME CHANGE: 20131030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Meyer Christian CENTRAL INDEX KEY: 0001693826 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36294 FILM NUMBER: 17625903 MAIL ADDRESS: STREET 1: FREDERIKKEVEJ 32 CITY: HUMLEBAEK STATE: G7 ZIP: 3050 4/A 1 doc1.xml FORM 4/A X0306 4/A 2017-01-27 2017-01-31 0 0001590560 uniQure N.V. QURE 0001693826 Meyer Christian C/O UNIQURE N.V. MEIBERGDREFF 61 AMSTERDAM P7 1005 BA NETHERLANDS 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 5.37 2017-01-27 4 A 0 43000 0 A 2027-01-27 Ordinary Shares 43000 43000 D Preformance Share Unit 0 2017-01-27 4 A 0 43500 0 A Ordinary Shares 43500 43500 D The Stock Option vests 25% on January 27, 2018 and 6.25% quarterly thereafter until fully vested. Performance Shares Units of a maximum of 43,250 shares of the Company's Ordinary Shares were granted on January 27, 2017. The Board of Directors shall determine how many Performance Share Units are to be granted in conjunction with a review of certain performance goals associated with the grant. Any such Performance Share Units granted by the Board of Directors shall vest 100% on January 27, 2020. Expiration date is not applicable. Due to clerical error, the Form 4, as originally filed, incorrectly reports the number of options granted as 43,250 and the number of performance share units granted as 43,250. The Form 4, as amended by this Form 4/A, correctly reports such information. See Exhibit 24 - Power of Attorney Lauren M. Watson, Attorney-in-Fact 2017-02-21 EX-24.1 2 poa1.htm POA_CHRISTIANMEYER.HTM
POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints each of Robert Coniglio and Lauren M. Watson, or either of them acting individually, with full power of substitution, the undersigned's true and lawful attorney-in-fact to:
1. execute for and on behalf of the undersigned, in the undersigned's capacity as an officer or director or authorized person, as the case may be, of uniQure NV (the “Company”), Forms 3, 4 and 5 (and any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules thereunder;
2. do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5, complete and execute any amendments thereto, and timely file such form with the U.S. Securities and Exchange Commission (the “SEC”) and any securities exchange or similar authority, including without limitation the filing of a Form ID or any other documents necessary or appropriate to enable the undersigned to file the Forms 3, 4 and 5 electronically with the SEC;
3. seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any broker or financial institution, and the undersigned hereby authorizes any such person to release any such information to each of the undersigned's attorneys-in-fact appointed by this Power of Attorney and approves and ratifies any such release of information; and
4. take any other action in connection with the foregoing which, in the opinion of such attorneyin- fact, may be of benefit to, in the best interest of, or legally required by or for, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such information and disclosure as such attorney-in-fact may approve in such attorney-in- fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever required, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted.
The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request and on the behalf of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with, or any liability for the failure to comply with, any provision of Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 or 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to each of the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 20th day of December, 2016.

Signature
/s/ Christian Meyer
Christian Meyer